Tae‐Hyoung Kim

Ulsan College, Chung-Ang University Hospital

Papers

2

Total Citations

19

H-Index

2

About

Dr. Tae-Hyoung Kim is a urologic oncologist whose research focuses on optimizing surgical outcomes and long-term prognosis for prostate cancer patients. His work centers on two critical areas: refining intraoperative techniques to reduce positive surgical margins (PSM) and understanding how post-treatment complications affect survival. In a landmark 2020 study (11 citations), Dr. Kim investigated whether intraoperative frozen section analysis can reliably predict significant PSMs during robot-assisted laparoscopic prostatectomy, providing surgeons with real-time feedback to improve cancer clearance. Expanding his impact, a 2023 population-based study (8 citations) examined how urinary tract infections following radical prostatectomy or radiation therapy influence prostate cancer prognosis, revealing important links between infectious complications and patient outcomes. By bridging surgical precision with long-term survivorship, Dr. Kim’s research helps clinicians tailor treatments to minimize recurrence and improve quality of life. His work is particularly valuable for urologists seeking evidence-based strategies to reduce biochemical recurrence and manage post-treatment complications, making him a respected voice in prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
19
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Does intraoperative frozen section really predict significant positive surgical margins after robot-assisted laparoscopic prostatectomy? A retrospective study
11 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Ulsan College, Chung-Ang University Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago